153 related articles for article (PubMed ID: 19632205)
21. Gangliosides enhance migration of mouse B16-melanoma cells through artificial basement membrane alone or in presence of laminin or fibronectin.
Saha S; Mohanty KC; Mallick P
Indian J Exp Biol; 2005 Dec; 43(12):1130-8. PubMed ID: 16359123
[TBL] [Abstract][Full Text] [Related]
22. Membrane properties of cultured glial cells obtained mechanically or by enzymatic dissociation: differential alterations by gangliosides.
Bouchon B; Petegnief V; Rebel G
J Neurosci Res; 1995 Jul; 41(4):510-7. PubMed ID: 7473882
[TBL] [Abstract][Full Text] [Related]
23. Shedding of gangliosides by human medulloblastoma cells.
Chang F; Li R; Ladisch S
Exp Cell Res; 1997 Aug; 234(2):341-6. PubMed ID: 9260903
[TBL] [Abstract][Full Text] [Related]
24. Gangliosides that modulate membrane protein function.
Igarashi Y; Nojiri H; Hanai N; Hakomori S
Methods Enzymol; 1989; 179():521-41. PubMed ID: 2560130
[No Abstract] [Full Text] [Related]
25. An acidic glycosphingolipid, monosialo-ganglioside GM3, is a potent physiological inducer for monocytic differentiation of human promyelocytic leukemia cell line HL-60 cells.
Saito M; Terui Y; Nojiri H
Biochem Biophys Res Commun; 1985 Oct; 132(1):223-31. PubMed ID: 3864442
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside composition of differentiated Caco-2 cells resembles human colostrum and neonatal rat intestine.
Schnabl KL; Field C; Clandinin MT
Br J Nutr; 2009 Mar; 101(5):694-700. PubMed ID: 18713482
[TBL] [Abstract][Full Text] [Related]
27. Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937.
Nojiri H; Takaku F; Terui Y; Miura Y; Saito M
Proc Natl Acad Sci U S A; 1986 Feb; 83(3):782-6. PubMed ID: 3456169
[TBL] [Abstract][Full Text] [Related]
28. Effects of continuous and pulsatile PTH treatments on rat bone marrow stromal cells.
Yang C; Frei H; Burt HM; Rossi F
Biochem Biophys Res Commun; 2009 Mar; 380(4):791-6. PubMed ID: 19338754
[TBL] [Abstract][Full Text] [Related]
29. The differentiation of HL-60 cells in the synthetic medium induced by GM3 ganglioside.
Senoo H; Momoi T
Biosci Rep; 1985 Jun; 5(6):517-24. PubMed ID: 3862432
[TBL] [Abstract][Full Text] [Related]
30. Glycosphingolipid expression in solid tumours and transformed cell lines.
Berra B; Colombo I; Monteggia E; Montorfano G; Moretti S; Rapelli S; Sottocornola E
Indian J Biochem Biophys; 1997; 34(1-2):170-7. PubMed ID: 9343946
[TBL] [Abstract][Full Text] [Related]
31. Obesity causes a shift in metabolic flow of gangliosides in adipose tissues.
Tanabe A; Matsuda M; Fukuhara A; Miyata Y; Komuro R; Shimomura I; Tojo H
Biochem Biophys Res Commun; 2009 Feb; 379(2):547-52. PubMed ID: 19116132
[TBL] [Abstract][Full Text] [Related]
32. GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: ganglioside may regulate growth factor receptor function.
Bremer EG; Hakomori S
Biochem Biophys Res Commun; 1982 Jun; 106(3):711-8. PubMed ID: 6288031
[No Abstract] [Full Text] [Related]
33. Ganglioside-mediated metabolic synchronization of protein synthesis activity in cultured hepatocytes.
Brodsky VY; Nechaeva NV; Zvezdina ND; Novikova TE; Gvasava IG; Fateeva VI; Prokazova NV; Golovanova NK
Cell Biol Int; 2000; 24(4):211-22. PubMed ID: 10816322
[TBL] [Abstract][Full Text] [Related]
34. [Induction of anti-melanoma CTL by GM3 (NeuGc)-liposomes].
Harada Y; Taniguchi M
Nihon Rinsho; 1990 Feb; 48(2):411-6. PubMed ID: 1691797
[No Abstract] [Full Text] [Related]
35. Modified ganglioside as a possible modulator of transmembrane signaling mechanism through growth factor receptors: a preliminary note.
Hanai N; Nores G; Torres-Méndez CR; Hakomori S
Biochem Biophys Res Commun; 1987 Aug; 147(1):127-34. PubMed ID: 3498483
[TBL] [Abstract][Full Text] [Related]
36. Density-dependent expression of ganglioside GM3 by human skin fibroblasts in an all-or-none fashion, as a possible modulator of cell growth in vitro.
Rösner H; Greis C; Rodemann HP
Exp Cell Res; 1990 Oct; 190(2):161-9. PubMed ID: 2209718
[TBL] [Abstract][Full Text] [Related]
37. Change in the topographical distribution of GM3 during cell spreading and growth: immunostaining with monoclonal antibody against GM3.
Sakiyama H; Takahashi T; Hirabayashi Y; Taniguchi M
Cell Struct Funct; 1987 Feb; 12(1):93-105. PubMed ID: 3568153
[TBL] [Abstract][Full Text] [Related]
38. The capacity of connective tissue stromas to sustain myelopoiesis depends both upon the growth factors and the local intercellular environment.
Carvalho MA; Arcanjo K; Silva LC; Borojevic R
Biol Cell; 2000 Dec; 92(8-9):605-14. PubMed ID: 11374439
[TBL] [Abstract][Full Text] [Related]
39. Ganglioside GM3 as a modulator of differentiation of mouse myeloid leukemia cells (M1-T22).
Arai K; Taki T; Kondo A; Matsumoto M
Cell Struct Funct; 1988 Apr; 13(2):161-9. PubMed ID: 3164259
[TBL] [Abstract][Full Text] [Related]
40. Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile.
Zweegman S; Kessler FL; Kerkhoven RM; Heimerikx M; Celie JW; Janssen JJ; Huijgens PC; Drager AM; van den Born J
Matrix Biol; 2007 Sep; 26(7):561-71. PubMed ID: 17521897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
